Greenwich Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.38M | Sell |
140,297
-1,242
| -0.9% | -$32.5K | 0.12% | 90 |
|
|
2026
Q1 | $3.97M | Buy |
141,539
+465
| +0.3% | +$12.4K | 0.16% | 74 |
|
|
2025
Q4 | $3.51M | Buy |
141,074
+4,228
| +3% | +$107K | 0.16% | 78 |
|
|
2025
Q3 | $3.49M | Sell |
136,846
-1,143
| -0.8% | -$28.2K | 0.17% | 73 |
|
|
2025
Q2 | $3.35M | Buy |
137,989
+3,835
| +3% | +$89.4K | 0.16% | 63 |
|
|
2025
Q1 | $3.4M | Buy |
134,154
+3,673
| +3% | +$96.1K | 0.26% | 50 |
|
|
2024
Q4 | $3.46M | Sell |
130,481
-5,982
| -4% | -$162K | 0.24% | 51 |
|
|
2024
Q3 | $3.95M | Buy |
136,463
+3,616
| +3% | +$105K | 0.27% | 46 |
|
|
2024
Q2 | $3.72M | Sell |
132,847
-642
| -0.5% | -$17.7K | 0.27% | 46 |
|
|
2024
Q1 | $3.7M | Buy |
133,489
+10,709
| +9% | +$297K | 0.3% | 47 |
|
|
2023
Q4 | $3.54M | Sell |
122,780
-352
| -0.3% | -$10.6K | 0.35% | 44 |
|
|
2023
Q3 | $4.08M | Sell |
123,132
-1,010
| -0.8% | -$35.7K | 0.43% | 35 |
|
|
2023
Q2 | $4.55M | Buy |
124,142
+438
| +0.4% | +$17K | 0.48% | 30 |
|
|
2023
Q1 | $5.05M | Buy |
123,704
+461
| +0.4% | +$19.9K | 0.55% | 24 |
|
|
2022
Q4 | $6.32M | Buy |
123,243
+135
| +0.1% | +$6.47K | 0.69% | 21 |
|
|
2022
Q3 | $5.39M | Sell |
123,108
-355
| -0.3% | -$17.3K | 0.57% | 21 |
|
|
2022
Q2 | $6.47M | Buy |
123,463
+476
| +0.4% | +$24.3K | 0.86% | 19 |
|
|
2022
Q1 | $6.37M | Sell |
122,987
-219
| -0.2% | -$11.4K | 0.65% | 22 |
|
|
2021
Q4 | $7.28M | Buy |
123,206
+2,648
| +2% | +$131K | 0.59% | 21 |
|
|
2021
Q3 | $5.18M | Buy |
120,558
+9,159
| +8% | +$406K | 0.43% | 24 |
|
|
2021
Q2 | $4.36M | Buy |
111,399
+3,994
| +4% | +$155K | 0.37% | 31 |
|
|
2021
Q1 | $3.89M | Sell |
107,405
-1,004
| -0.9% | -$35.6K | 0.31% | 34 |
|
|
2020
Q4 | $3.99M | Sell |
108,409
-6,716
| -6% | -$246K | 0.35% | 31 |
|
|
2020
Q3 | $4.01M | Buy |
115,125
+24
| +0% | +$841 | 0.72% | 25 |
|
|
2020
Q2 | $3.57M | Buy |
115,101
+612
| +0.5% | +$20.8K | 0.68% | 27 |
|
|
2020
Q1 | $3.54M | Buy |
114,489
+3,916
| +4% | +$133K | 0.76% | 29 |
|
|
2019
Q4 | $4.11M | Buy |
110,573
+503
| +0.5% | +$17.9K | 0.83% | 28 |
|
|
2019
Q3 | $3.75M | Sell |
110,070
-1,500
| -1% | -$54.5K | 0.73% | 30 |
|
|
2019
Q2 | $4.59M | Sell |
111,570
-3,387
| -3% | -$134K | 0.79% | 25 |
|
|
2019
Q1 | $4.63M | Sell |
114,957
-701
| -0.6% | -$28.1K | 0.82% | 25 |
|
|
2018
Q4 | $4.79M | Buy |
115,658
+599
| +0.5% | +$24.9K | 0.95% | 23 |
|
|
2018
Q3 | $4.81M | Buy |
115,059
+811
| +0.7% | +$31.2K | 0.84% | 24 |
|
|
2018
Q2 | $3.93M | Buy |
114,248
+3,083
| +3% | +$105K | 0.7% | 30 |
|
|
2018
Q1 | $3.74M | Buy |
111,165
+418
| +0.4% | +$14.4K | 0.59% | 34 |
|
|
2017
Q4 | $3.81M | Buy |
110,747
+3,336
| +3% | +$114K | 0.64% | 32 |
|
|
2017
Q3 | $3.64M | Sell |
107,411
-14,681
| -12% | -$472K | 0.63% | 31 |
|
|
2017
Q2 | $3.89M | Sell |
122,092
-510
| -0.4% | -$16.1K | 0.65% | 30 |
|
|
2017
Q1 | $3.98M | Sell |
122,602
-20,786
| -14% | -$655K | 0.53% | 30 |
|
|
2016
Q4 | $4.42M | Buy |
143,388
+1,254
| +0.9% | +$38.3K | 0.56% | 26 |
|
|
2016
Q3 | $4.57M | Sell |
142,134
-65
| -0% | -$2.17K | 0.81% | 22 |
|
|
2016
Q2 | $4.75M | Buy |
142,199
+937
| +0.7% | +$29.9K | 1.15% | 18 |
|
|
2016
Q1 | $3.97M | Sell |
141,262
-21,563
| -13% | -$616K | 1.03% | 17 |
|
|
2015
Q4 | $4.99M | Hold |
162,825
| – | – | 1.22% | 16 |
|
|
2015
Q3 | $4.85M | Sell |
162,825
-181,303
| -53% | -$5.81M | 1.17% | 21 |
|
|
2015
Q2 | $10.9M | Sell |
344,128
-79,084
| -19% | -$2.58M | 1.4% | 24 |
|
|
2015
Q1 | $14M | Sell |
423,212
-25
| -0% | -$795 | 1.58% | 18 |
|
|
2014
Q4 | $12.5M | Buy |
423,237
+99
| +0% | +$2.84K | 0.83% | 26 |
|
|
2014
Q3 | $11.9M | Buy |
423,138
+50
| +0% | +$1.4K | 0.8% | 27 |
|
|
2014
Q2 | $11.9M | Sell |
423,088
-69
| -0% | -$1.97K | 0.79% | 28 |
|
|
2014
Q1 | $12.9M | Sell |
423,157
-47
| -0% | -$1.4K | 0.9% | 24 |
|
|
2013
Q4 | $12.3M | Sell |
423,204
-359
| -0.1% | -$10.4K | 1.24% | 29 |
|
|
2013
Q3 | $11.5M | Buy |
423,563
+252
| +0.1% | +$6.86K | 0.83% | 26 |
|
|
2013
Q2 | $11.2M | Buy |
+423,311
| New | +$11.7M | 0.83% | 29 |
|
Other funds holding PFE
Greenwich Wealth Management's PFE Position: Q2 2026 in Review
Greenwich Wealth Management reduced its Pfizer (PFE) stake by 0.88% in Q2 2026, selling an estimated $32.5K and leaving 140,297 shares worth $3.38M. The position accounts for 0.12% of the portfolio, ranked #90.
Greenwich Wealth Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $14M in Q1 2015. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Greenwich Wealth Management held 140,297 shares of Pfizer worth $3.38M as of Q2 2026.
- Greenwich Wealth Management sold 1,242 Pfizer shares in Q2 2026, an estimated $32.5K.
- Pfizer made up 0.12% of Greenwich Wealth Management's portfolio in Q2 2026, its #90 holding.
- Greenwich Wealth Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Greenwich Wealth Management's Pfizer position peaked at $14M in Q1 2015.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Greenwich Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.